CONTACT SITEMAP Vecata Venture Property projects News History Organization Annual Accounts Ownership Portfolio Network and partners New Investments Strategy Biotech Medico IT Technology Other Fluxome Ltd. LiPlasome Pharma Ltd. Mirrx Therapeutics Ltd. QuantiBact Ltd. ReceptIcon Plc. Tina Holding Plc. Chempaq Ltd. Scandinavian Micro Biodevices Plc. Vivostat Ltd. Zoomio Ltd. Cardlab Plc. Noiselimit ApS 3D Visiontech Plc. Columbus E. Plc. Land for sale (business projects) Lysholt Park Be Retainment Park www.vecata.com > Venture   Vecata's ventureportefølje består af selskaber indenfor følgende forretningsområder:   Venture Network and partners New Investments Strategy Portfolio Biotech Fluxome Ltd. | LiPlasome Pharma Ltd. | Mirrx Therapeutics Ltd. | QuantiBact Ltd. | ReceptIcon Plc. | Tina Holding Plc. Medico Chempaq Ltd. | Scandinavian Micro Biodevices Plc. | Vivostat Ltd. IT Zoomio Ltd. Technology Cardlab Plc. | Noiselimit ApS | 3D Visiontech Plc. Other Columbus E. Plc.     Disclaimer  |  Privacy Policy VECATA A/S, Dandyvej 19 DK 7100 Vejle | Tlf. +45 72 15 15 00 | Fax. +45 72 15 19 09 | Email: info@vecata.com